{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:35:12Z","timestamp":1778657712715,"version":"3.51.4"},"reference-count":56,"publisher":"Elsevier BV","issue":"37","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T00:00:00Z","timestamp":1565136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.vaccine.2019.07.095","type":"journal-article","created":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T18:27:45Z","timestamp":1565116065000},"page":"5567-5577","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice"],"prefix":"10.1016","volume":"37","author":[{"given":"Guha","family":"Asthagiri Arunkumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meagan","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7362-643X","authenticated-orcid":false,"given":"Vincent","family":"Pavot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Aramouni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andriani","family":"Ioannou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Lambe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6823-9750","authenticated-orcid":false,"given":"Sarah","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4121-776X","authenticated-orcid":false,"given":"Florian","family":"Krammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.07.095_b0005","doi-asserted-by":"crossref","DOI":"10.1038\/s41577-019-0143-6","article-title":"The human antibody response to influenza A virus infection and vaccination","author":"Krammer","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2019.07.095_b0010","doi-asserted-by":"crossref","first-page":"15279","DOI":"10.1038\/srep15279","article-title":"H3N2 mismatch of 2014\u201315 Northern Hemisphere influenza vaccines and head-to-head comparison between human and ferret antisera derived antigenic maps","volume":"5","author":"Xie","year":"2015","journal-title":"Sci Rep."},{"key":"10.1016\/j.vaccine.2019.07.095_b0015","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/(SICI)1096-9071(200005)61:1<94::AID-JMV15>3.0.CO;2-C","article-title":"Mismatch between the 1997\/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly","volume":"61","author":"de Jong","year":"2000","journal-title":"J Med Virol."},{"key":"10.1016\/j.vaccine.2019.07.095_b0020","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.cmi.2017.02.009","article-title":"Universal influenza virus vaccines and therapeutic antibodies","volume":"23","author":"Nachbagauer","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2019.07.095_b0025","article-title":"Clinical advances in viral-vectored influenza vaccines","volume":"6","author":"Sebastian","year":"2018","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2019.07.095_b0030","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.coi.2018.04.001","article-title":"Development of next generation hemagglutinin-based broadly protective influenza virus vaccines","volume":"53","author":"Nachbagauer","year":"2018","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2019.07.095_b0035","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.virol.2018.03.013","article-title":"Broadly protective anti-hemagglutinin stalk antibodies induced by live attenuated influenza vaccine expressing chimeric hemagglutinin","volume":"518","author":"Isakova-Sivak","year":"2018","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2019.07.095_b0040","doi-asserted-by":"crossref","DOI":"10.1038\/npjvaccines.2016.15","article-title":"A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces prtective stalk-reactive antibodies in mice","volume":"1","author":"Nachbagauer","year":"2016","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2019.07.095_b0045","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00286-17","article-title":"Chimeric hemagglutinin constructs induce broad protection against Influenza B virus challenge in the mouse model","volume":"91","author":"Ermler","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.07.095_b0050","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1128\/JVI.00641-13","article-title":"Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies","volume":"87","author":"Krammer","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.07.095_b0055","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1128\/JVI.03183-13","article-title":"H3 stalk-based chimeric hemagglutinin influenza virus constructs protect mice from H7N9 challenge","volume":"88","author":"Krammer","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.07.095_b0060","article-title":"A live-attenuated prime, inactivated boost vaccination strategy with chimeric hemagglutinin-based universal influenza virus vaccines provides protection in ferrets: a confirmatory study","volume":"6","author":"Nachbagauer","year":"2018","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2019.07.095_b0065","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41541-017-0026-4","article-title":"A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies","volume":"2","author":"Nachbagauer","year":"2017","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2019.07.095_b0070","doi-asserted-by":"crossref","first-page":"10435","DOI":"10.1128\/JVI.01715-13","article-title":"Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses","volume":"87","author":"Margine","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.07.095_b0075","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1128\/JVI.03004-13","article-title":"Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets","volume":"88","author":"Krammer","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.07.095_b0080","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1128\/JVI.02481-15","article-title":"Hemagglutinin stalk immunity reduces influenza virus replication and transmission in ferrets","volume":"90","author":"Nachbagauer","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.07.095_b0085","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1128\/JVI.02598-15","article-title":"Vaccination with vesicular stomatitis virus-vectored chimeric hemagglutinins protects mice against divergent influenza virus challenge strains","volume":"90","author":"Ryder","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.07.095_b0090","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1128\/jb.89.1.170-174.1965","article-title":"Induction, of partial specific heterotypic immunity in mice by a single infection with influenza A virus","volume":"89","author":"Schulman","year":"1965","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2019.07.095_b0095","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1128\/JVI.72.7.5648-5653.1998","article-title":"Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA","volume":"72","author":"Ulmer","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.07.095_b0100","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.vaccine.2006.08.036","article-title":"Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice","volume":"25","author":"Kreijtz","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.095_b0105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJM198307073090103","article-title":"Cytotoxic T-cell immunity to influenza","volume":"309","author":"McMichael","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.07.095_b0110","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1164\/rccm.201411-1988OC","article-title":"Cell-mediated protection against seasonal and pandemic influenza. Results of the flu watch cohort study","volume":"191","author":"Hayward","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2019.07.095_b0115","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nm.2612","article-title":"Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans","volume":"18","author":"Wilkinson","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2019.07.095_b0120","article-title":"Harnessing the power of T cells: the promising hope for a universal influenza vaccine","volume":"6","author":"Clemens","year":"2018","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2019.07.095_b0125","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fimmu.2016.00041","article-title":"T-cell immunity to influenza in older adults: a pathophysiological framework for development of more effective vaccines","volume":"7","author":"McElhaney","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2019.07.095_b0130","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/mt.2013.284","article-title":"Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved Influenza A antigens","volume":"22","author":"Antrobus","year":"2014","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2019.07.095_b0135","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/mt.2013.162","article-title":"Coadministration of seasonal influenza vaccine and MVA-NP+M1 simultaneously achieves potent humoral and cell-mediated responses","volume":"22","author":"Antrobus","year":"2014","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2019.07.095_b0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062778","article-title":"Examination of influenza specific T cell responses after influenza virus challenge in individuals vaccinated with MVA-NP+M1 vaccine","volume":"8","author":"Powell","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.07.095_b0145","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/srep01443","article-title":"Immunity against heterosubtypic influenza virus induced by adenovirus and MVA expressing nucleoprotein and matrix protein-1","volume":"3","author":"Lambe","year":"2013","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2019.07.095_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/ciq015","article-title":"Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1","volume":"52","author":"Berthoud","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.07.095_b0155","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/cid\/cis327","article-title":"Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP+M1, in humans","volume":"55","author":"Lillie","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.07.095_b0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048322","article-title":"A T cell-inducing influenza vaccine for the elderly: safety and immunogenicity of MVA-NP+M1 in adults aged over 50 years","volume":"7","author":"Antrobus","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.07.095_b0165","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ebiom.2018.02.011","article-title":"Heterologous two-dose vaccination with simian adenovirus and poxvirus vectors elicits long-lasting cellular immunity to influenza virus A in healthy adults","volume":"29","author":"Coughlan","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.vaccine.2019.07.095_b0170","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1600939","article-title":"Novel bivalent viral-vectored vaccines induce potent humoral and cellular immune responses conferring protection against stringent influenza A virus challenge","author":"Tully","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.07.095_b0175","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1002\/eji.201242922","article-title":"Improved adjuvanting of seasonal influenza vaccines: preclinical studies of MVA-NP+M1 coadministration with inactivated influenza vaccine","volume":"43","author":"Mullarkey","year":"2013","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2019.07.095_b0180","doi-asserted-by":"crossref","DOI":"10.3791\/51112-v","article-title":"Expression of functional recombinant hemagglutinin and neuraminidase proteins from the novel H7N9 influenza virus using the baculovirus expression system","author":"Margine","year":"2013","journal-title":"J Vis Exp"},{"key":"10.1016\/j.vaccine.2019.07.095_b0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043603","article-title":"A carboxy-terminal trimerization domain stabilizes conformational epitopes on the stalk domain of soluble recombinant hemagglutinin substrates","volume":"7","author":"Krammer","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.07.095_b0190","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-1-4939-6869-5_6","article-title":"Generation and Production of Modified Vaccinia Virus Ankara (MVA) as a vaccine vector","volume":"1581","author":"Pavot","year":"2017","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.vaccine.2019.07.095_b0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040167","article-title":"Expression and cellular immunogenicity of a transgenic antigen driven by endogenous poxviral early promoters at their authentic loci in MVA","volume":"7","author":"Orubu","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.07.095_b0200","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.vaccine.2009.11.056","article-title":"Modified H5 promoter improves stability of insert genes while maintaining immunogenicity during extended passage of genetically engineered MVA vaccines","volume":"28","author":"Wang","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.095_b0205","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1006\/viro.1998.9290","article-title":"The DF-1 chicken fibroblast cell line: transformation induced by diverse oncogenes and cell death resulting from infection by avian leukosis viruses","volume":"248","author":"Himly","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2019.07.095_b0210","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.4049\/jimmunol.1003783","article-title":"Combining liver- and blood-stage malaria viral-vectored vaccines: investigating mechanisms of CD8+ T cell interference","volume":"187","author":"Forbes","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.07.095_b0215","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm.3927","article-title":"Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection","volume":"21","author":"Yassine","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2019.07.095_b0220","doi-asserted-by":"crossref","DOI":"10.1126\/science.aac7263","article-title":"A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen","author":"Impagliazzo","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2019.07.095_b0225","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.chom.2015.10.003","article-title":"The quest for a universal flu vaccine: headless HA 2.0","volume":"18","author":"Krammer","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2019.07.095_b0230","doi-asserted-by":"crossref","unstructured":"Corbett KS, Moin SM, Yassine HM, Cagigi A, Kanekiyo M, Boyoglu-Barnum S, et al. Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages. MBio 2019; 10.","DOI":"10.1128\/mBio.02810-18"},{"key":"10.1016\/j.vaccine.2019.07.095_b0235","doi-asserted-by":"crossref","unstructured":"Nachbagauer R, Choi A, Izikson R, Cox MM, Palese P, Krammer F. Age dependence and isotype specificity of influenza virus hemagglutinin stalk-reactive antibodies in humans. MBio 2016; 7.","DOI":"10.1128\/mBio.01996-15"},{"key":"10.1016\/j.vaccine.2019.07.095_b0240","doi-asserted-by":"crossref","DOI":"10.1038\/ni.3684","article-title":"Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins","author":"Nachbagauer","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2019.07.095_b0245","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.4049\/jimmunol.1003057","article-title":"Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus","volume":"186","author":"LaMere","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.07.095_b0250","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1128\/JVI.00150-11","article-title":"Regulation of antinucleoprotein IgG by systemic vaccination and its effect on influenza virus clearance","volume":"85","author":"Lamere","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.07.095_b0255","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ebiom.2016.04.029","article-title":"What lies beneath: antibody dependent natural killer cell activation by antibodies to internal influenza virus proteins","volume":"8","author":"Vanderven","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.vaccine.2019.07.095_b0260","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4049\/immunohorizons.1900022","article-title":"Chimeric hemagglutinin-based influenza virus vaccines induce protective stalk-specific humoral immunity and cellular responses in mice","volume":"3","author":"Choi","year":"2019","journal-title":"Immunohorizons"},{"key":"10.1016\/j.vaccine.2019.07.095_b0265","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/imr.12662","article-title":"CD4 T cells in protection from influenza virus: viral antigen specificity and functional potential","volume":"284","author":"Sant","year":"2018","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2019.07.095_b0270","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/infdis\/jiu662","article-title":"Seasonal influenza can poise hosts for CD4 T-Cell immunity to H7N9 avian influenza","volume":"212","author":"Richards","year":"2015","journal-title":"J Infect Dis."},{"key":"10.1016\/j.vaccine.2019.07.095_b0275","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/infdis\/jiu616","article-title":"Effect of influenza A(H5N1) vaccine prepandemic priming on CD4+ T-cell responses","volume":"211","author":"Nayak","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.07.095_b0280","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.humimm.2009.06.004","article-title":"Genome-wide screening of human T-cell epitopes in influenza A virus reveals a broad spectrum of CD4(+) T-cell responses to internal proteins, hemagglutinins, and neuraminidases","volume":"70","author":"Babon","year":"2009","journal-title":"Hum Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19310163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19310163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:34:43Z","timestamp":1759401283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19310163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":56,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0264410X19310163"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.07.095","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.07.095","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}